These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 849674)

  • 1. Pharmacokinetics of chlorpromazine after single and chronic dosage.
    Dahl SG; Strandjord RE
    Clin Pharmacol Ther; 1977 Apr; 21(4):437-48. PubMed ID: 849674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of methotrimeprazine after single and multiple doses.
    Dahl SG
    Clin Pharmacol Ther; 1976 Apr; 19(4):435-42. PubMed ID: 1269194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of chlorpromazine in normal volunteers.
    Loo JC; Midha KK; McGilveray IJ
    Commun Psychopharmacol; 1980; 4(2):121-9. PubMed ID: 7428333
    [No Abstract]   [Full Text] [Related]  

  • 4. Bioavailability analysis of chlorpromazine in humans from pupilometric data.
    Smolen VF; Murdock HR; Williams EJ
    J Pharmacol Exp Ther; 1975 Dec; 195(3):404-15. PubMed ID: 1195127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chlorpromazine: concentrations in plasma, excretion in urine and duration of effect.
    Curry SH
    Proc R Soc Med; 1971 Mar; 64(3):285-9. PubMed ID: 5551485
    [No Abstract]   [Full Text] [Related]  

  • 6. Urinary excretion of chlorpromazine metabolites following single doses and in steady-state conditions.
    Hollister LE; Curry SH
    Res Commun Chem Pathol Pharmacol; 1971 May; 2(3):330-8. PubMed ID: 4948435
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacokinetics of chlorpromazine and key metabolites.
    Yeung PK; Hubbard JW; Korchinski ED; Midha KK
    Eur J Clin Pharmacol; 1993; 45(6):563-9. PubMed ID: 8157044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of chlorimipramine, chlorpromazine and their N-dealkylated metabolites in plasma of healthy volunteers after a single oral dose of the parent compounds.
    Della Corte L; Valoti M; Palmi M; Giovannini MG; Sgaragli GP
    J Pharm Pharmacol; 1993 Sep; 45(9):825-9. PubMed ID: 7903373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluphenazine decanoate trial in chronic in-patient schizophrenics failing to absorb oral chlorpromazine.
    Adamson L; Curry SH; Bridges PK; Firestone AF; Lavin NI; Lewis DM; Watson RD; Xavier CM; Anderson JA
    Dis Nerv Syst; 1973; 34(4):181-91. PubMed ID: 4711886
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative plasma concentrations of quinidine following administration of one intramuscular and three oral formulations to 13 human subjects.
    Mason WD; Covinsky JO; Valentine JL; Kelly KL; Weddle OH; Martz BL
    J Pharm Sci; 1976 Sep; 65(9):1325-9. PubMed ID: 966146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The bioavailability of orphenadrine hydrochloride after intramuscular and oral administration.
    Rutigliano G; Labout JJ
    J Int Med Res; 1982; 10(6):447-50. PubMed ID: 7152086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse reactions to chlorpromazine in psychiatric patients.
    Swett C
    Dis Nerv Syst; 1974 Nov; 35(11):509-11. PubMed ID: 17896459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological response data for comparative bioavailability studies of chlorpromazine oral dosage forms in humans: I. Pupilometry.
    Smolen VF; Murdock HR; Stoltman WP; Clevenger JW; Combs LW; Williams EJ
    J Clin Pharmacol; 1975; 15(11-12):734-51. PubMed ID: 1104666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chlorpromazine excretion by the neonate following chronic in utero exposure.
    Nielsen HC; Wiriyathian S; Rosenfeld R; Leveno K; Garriott JC
    Pediatr Pharmacol (New York); 1983; 3(1):1-5. PubMed ID: 6646875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and Pharmacodynamics of Follicle-Stimulating Hormone in Healthy Women Receiving Single and Multiple Doses of Highly Purified Human Menotrophin and Urofollitrophin.
    Di Stefano AF; Rusca A; Radicioni MM; Loprete L; Binelli D; Caccia G; Cometti B
    Clin Drug Investig; 2016 Dec; 36(12):1031-1044. PubMed ID: 27638053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-pressure liquid chromatographic determination of promethazine plasma levels in the dog after oral, intramuscular, and intravenous dosage.
    Patel RB; Welling PG
    J Pharm Sci; 1982 May; 71(5):529-32. PubMed ID: 7097498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Destruction of chlorpromazine during absorption in the rat in vivo and in vitro.
    Curry SH; D'Mello A; Mould GP
    Br J Pharmacol; 1971 Jul; 42(3):403-11. PubMed ID: 5560899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and dosage of chlorpromazine in goats.
    Nawaz M
    J Vet Pharmacol Ther; 1981 Jun; 4(2):157-63. PubMed ID: 7349328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study of the kinetics of chlorpromazine sulfoxide by a specific radioimmunoassay after a single oral dose of chlorpromazine in healthy volunteers.
    Yeung PK; Hubbard JW; Cooper JK; Midha KK
    J Pharmacol Exp Ther; 1983 Sep; 226(3):833-8. PubMed ID: 6887014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma pyridostigmine levels in patients with myasthenia gravis.
    Calvey TN; Chan K
    Clin Pharmacol Ther; 1977 Feb; 21(2):187-93. PubMed ID: 837637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.